Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs

BSE3926.4514.55 (+0.37 %)

PREV CLOSE ( ) 3911.90

OPEN PRICE ( ) 3900.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3481

TODAY'S LOW / HIGH ( )3860.05 3938.40

52 WK LOW / HIGH ( )3050.15 4104

NSE3929.0018.25 (+0.47 %)

PREV CLOSE( ) 3910.75

OPEN PRICE ( ) 3887.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 3929.00 (155)

VOLUME 31964

TODAY'S LOW / HIGH( ) 3870.00 3965.00

52 WK LOW / HIGH ( )3051 4100

Chairman	Ramesh BV Nimmagadda
Managing Director	Murali K Divi
Company Secretary	Satish Choudhury
Executive Director	N V Ramana
Non Executive Independent Director	G Suresh Kumar R Ranga Rao KVK Seshavataram S Ganapaty Sunaina Singh K V Chowdary
Whole Time Director	Kiran S Divi
Whole Time Director - Commercial	Nilima Prasad Divi

Incorporation Year : 12-10 1990

Registered Office :

Address : 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli Hyderabad,
Telangana-500032 .

Phone : 040 66966300

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX